Argenx CEO on bike with patient with rare disease: 'There is a need for more effective medication'

Briton Clive Phillips, who suffers from a rare muscle disorder, wants to ride his own Tour de France soon. He has already cycled through Ghent with Tim Van Hauwermeiren, the CEO of Argenx, which is developing a new therapy for patients like Phillips. ‘It is now like putting out a fire with a fire extinguisher while the fire keeps coming back.’